Presenilin Biology and the Mechanism of Alzheimer's Disease

早老素生物学和阿尔茨海默病的机制

基本信息

  • 批准号:
    8318127
  • 负责人:
  • 金额:
    $ 122.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-30 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The discovery of presenilins as ubiquitous intramembrane proteases in metazoans exemplifies an emerging trend in biology. The traditional distinction between basic and applied research has become increasingly blurred, as studies initiated with a strictly disease-oriented focus uncover fundamental biological mechanisms. In this renewal application, ten investigators who have collaborated successfully during the last decade on the normal and pathological biology of presenilin (PS) wish to extend their productive interactions into new experiments that will further illuminate the structure-function relationships of PS/ ? -secretase in normal biology and the role of this unusual multi-protein complex and various related gene products in the genesis of Alzheimer's disease. Based on extensive preliminary data in each of our four interrelated projects and supported by three vital cores, we will pursue numerous Specific Aims that include: 1. attempting to determine the structure of PS/ ?-secretase by performing cryo-electron microscopy of the purified, active complex as well as x-ray crystallography of the individual components; 2. extending our recent discovery that cholesterol dramatically enhances the catalytic activity of purified ? -secretase and that membrane lipids in general appear to represent the most potent regulators of both A¿ production and Notch cleavage; 3. performing extensive genomic, functional genetic and protein analyses searching for novel lateonset AD candidate genes potentially implicated in presenilin-related pathways; 4. using advanced microscopy approaches in living cells (bimolecular fluorescence complementation; FLIM) to image and quantify the conformations and interactions of presenilin with APP, with new candidate genes emerging from (2), and with lipids and ? -modulating compounds identified herein; 5. identifying common binding partners and common subcellular processing pathways for the (32 subunit of NaJ, APP and APLP2, three proteins that are processed identically by both (3- and y-secretase. 6. performing an unbiased proteomics screen to more fully define the " ? -secretome", i.e., the extent of unknown ?-substrates. These and numerous additional aims and sub-aims will be pursued collaboratively across our 4 projects, with progress in one project modifying experimental plans in another. In short, we are anxious to continue our close interaction to bring greater clarity to exactly how PS and its associated proteins and lipids process a host of substrates within membranes in health and disease. Lay summary: Ten experienced scientists who have collaborated productively for the past decade wish to address the structure and the functions of an unusual protein-cutting enzyme that is required for life in all multi-cellular animals and implicated in the causation of Alzheimer's disease.
描述(由申请人提供):早老素作为后生动物中普遍存在的膜内蛋白酶的发现证实了生物学中的一个新兴趋势。基础研究和应用研究之间的传统区别已经变得越来越模糊,因为严格以疾病为导向的研究揭示了基本的生物学机制。在这个更新的应用程序中,10名研究人员谁合作成功,在过去十年中的正常和病理生物学早老素(PS)希望延长他们的生产相互作用到新的实验,将进一步阐明PS/?- 分泌酶在正常生物学中的作用以及这种不寻常的多蛋白复合物和各种相关基因产物在阿尔茨海默病发生中的作用。基于我们四个相互关联的项目中每个项目的大量初步数据,并得到三个重要核心的支持,我们将追求许多具体目标,包括:1。试图确定PS/?-通过对纯化的活性复合物进行冷冻电子显微镜检查以及对各个组分进行X射线晶体学检查来鉴定分泌酶; 2.扩展我们最近的发现,胆固醇显着提高催化活性的纯化?- 分泌酶和膜脂质一般似乎代表最有效的调节剂的生产和Notch裂解; 3.进行广泛的基因组、功能遗传和蛋白质分析,寻找可能与早老蛋白相关途径有关的新的迟发性AD候选基因; 4.使用先进的显微镜方法在活细胞(双分子荧光互补; FLIM)的图像和定量的构象和相互作用的早老素与APP,与新的候选基因出现(2),与脂质和?- 本文鉴定的调节化合物; 5.鉴定NaJ、APP和APLP 2的β 2亚基的共同结合配偶体和共同亚细胞加工途径,这三种蛋白质被β-和γ-分泌酶相同地加工。6.进行无偏见的蛋白质组学筛选,以更全面地定义“?- 分泌组”,即,未知的程度?印刷受体.这些以及许多其他目标和子目标将在我们的4个项目中协同实现,一个项目的进展将修改另一个项目的实验计划。简而言之,我们渴望继续我们的密切互动,以更清楚地了解PS及其相关蛋白质和脂质如何在健康和疾病中处理膜内的许多底物。敷设总结:十位经验丰富的科学家在过去十年中进行了富有成效的合作,他们希望解决一种不寻常的蛋白质切割酶的结构和功能,这种酶是所有多细胞动物生命所必需的,并与阿尔茨海默病的病因有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENNIS J SELKOE其他文献

DENNIS J SELKOE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENNIS J SELKOE', 18)}}的其他基金

A new look at mechanism-based Alzheimer's Disease biomarkers in blood
对血液中基于机制的阿尔茨海默病生物标志物的新认识
  • 批准号:
    9763401
  • 财政年份:
    2018
  • 资助金额:
    $ 122.1万
  • 项目类别:
Pathological Changes of Alpha-Synuclein Structure in the Brain
大脑α-突触核蛋白结构的病理变化
  • 批准号:
    9788107
  • 财政年份:
    2018
  • 资助金额:
    $ 122.1万
  • 项目类别:
Biology of Native Alpha-Synuclein Tetramers in Parkinson's Disease
天然 α-突触核蛋白四聚体在帕金森病中的生物学
  • 批准号:
    8631204
  • 财政年份:
    2014
  • 资助金额:
    $ 122.1万
  • 项目类别:
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
细胞源性 Abeta 寡聚物的致病机制
  • 批准号:
    8337011
  • 财政年份:
    2011
  • 资助金额:
    $ 122.1万
  • 项目类别:
AMYLOID B-PROTEIN AND IMMUNE MARKERS IN HUMAN BLOOD
人类血液中的 B 淀粉样蛋白和免疫标记物
  • 批准号:
    7719366
  • 财政年份:
    2008
  • 资助金额:
    $ 122.1万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7498199
  • 财政年份:
    2007
  • 资助金额:
    $ 122.1万
  • 项目类别:
AMYLOID B-PROTEIN AND IMMUNE MARKERS IN HUMAN BLOOD
人类血液中的 B 淀粉样蛋白和免疫标记物
  • 批准号:
    7607424
  • 财政年份:
    2007
  • 资助金额:
    $ 122.1万
  • 项目类别:
PURIFICATION AND RECONSTITUTION OF ACTIVE GAMMA SECRETASE COMPLEX
活性伽玛分泌酶复合物的纯化和重构
  • 批准号:
    7483170
  • 财政年份:
    2007
  • 资助金额:
    $ 122.1万
  • 项目类别:
Alpha-Synuclein, PUFA and Membrane Vesicles-Health/PD
α-突触核蛋白、PUFA 和膜囊泡-健康/PD
  • 批准号:
    7032775
  • 财政年份:
    2006
  • 资助金额:
    $ 122.1万
  • 项目类别:
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
细胞源性 Abeta 寡聚物的致病机制
  • 批准号:
    7027342
  • 财政年份:
    2006
  • 资助金额:
    $ 122.1万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 122.1万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 122.1万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 122.1万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 122.1万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 122.1万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 122.1万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 122.1万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 122.1万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 122.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 122.1万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了